Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fusing genes could hold leukaemia treatment clues

17.11.2006
Pioneering cancer scientists at The University of Nottingham are to investigate why a rare form of leukaemia is triggered when two genes fuse together.

It is hoped the research will lead to the discovery of potential new drugs to treat the rare form of acute myeloid leukaemia, which currently affects 2,000 adults and more than 100 children in the UK every year.

Professor David Heery and Dr Karin Kindle in the University’s School of Pharmacy have been awarded a £150,000 grant from the AICR (Association of International Cancer Research) to study how the abnormal fusion of MOZ and TIF2 genes affects bone marrow cells and, by doing so, contributes to the development of the cancer.

Professor Heery, head of the Division of Molecular and Cellular Sciences, said: “At least 50 genes have been identified that are involved in gene fusions associated with leukaemia. The key question is to discover how MOZ-TIF2 and similar fusion proteins affect cell function.

... more about:
»Treatment »affect »leukaemia

“This will be critical in the future discovery of potential new drug treatments for patients with this form of the disease.”

AICR’s scientific adviser Dr Mark Matfield believes the work will have important implications in better understanding a type of leukaemia for which the exact causes are, as yet, unknown.

“This is an aggressive form of cancer and although it can affect all ages it is more common in older people, with slightly more reported cases in men. The main lab tests used in diagnosis are a full blood count and bone marrow biopsy,” he said.

“Without treatment AML will rapidly cause death, but with modern treatment protocols the cure rate has improved significantly in patients who are under 60. Older people tend to do less well, partly because they are often unable to receive the very intensive therapy needed for effective management of the disease.”

Derek Napier, AICR’s Chief Executive, said the grant was in line with the charity’s policy of funding the most exciting and novel approaches to research worldwide.

“We believe it important to fund work that pushes the boundaries and Professor Heery and Dr Kindle are charged with tackling a great scientific challenge that could in future change the lives of tens of thousands of people in the UK across the world.”

Emma Thorne | alfa
Further information:
http://www.nottingham.ac.uk

Further reports about: Treatment affect leukaemia

More articles from Life Sciences:

nachricht Repairing damaged hearts with self-healing heart cells
22.08.2017 | National University Health System

nachricht Biochemical 'fingerprints' reveal diabetes progression
22.08.2017 | Umea University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>